Taiwan biotech looks outward in next phase of growth
· marian chu
AI Briefing
- • Taiwan's biotech sector is shifting focus from domestic health needs to international partnerships.
- • The sector is seeking licensing, clinical development, and a global role.
- • International collaborations are key to the next phase of growth for Taiwan's biotech.
Context
Taiwan's biotechnology sector was initially focused on domestic health needs, such as vaccines and drug manufacturing. The sector is now shifting its focus to international collaborations.
The sector's expansion into international partnerships and clinical development will likely play a significant role in its next phase of growth, as it seeks a bigger presence in the global biomedical industry.
Advertisement